COVID-19 vaccine uptake and hesitancy among HIV-infected men who have sex with men in mainland China: a cross-sectional survey

References

• London School of Hygiene & Tropical Medicine. COVID-19 vaccine tracker. 2021 [accessed 2021 Jul 24]. https://vac-lshtm.shinyapps.io/ncov_vaccine_landscape/ .
   Google Scholar
• The Guardian. Covid-19 vaccine: who are countries prioritising for first doses? 2020 [accessed 2021 Mar 30]. https://www.theguardian.com/world/2020/nov/18/covid-19-vaccine-who-are-countries-prioritising-for-first-doses .
   Google Scholar
• Our World in Data. Coronavirus (COVID-19) vaccinations. 2021 [accessed 2021 Jul 24]. https://ourworldindata.org/covid-vaccinations .
   Google Scholar
• Xinhuanet. China vaccinating key groups against COVID-19. 2020 [accessed 2021 Apr 5]. http://www.xinhuanet.com/english/2021-01/04/c_139641409.htm .
   Google Scholar
• Reuters. China says will vaccinate ‘key groups’ over winter, spring. 2020 [accessed 2021 Apr 5]. https://au.news.yahoo.com/china-vaccinate-key-groups-over-045323011.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAMTFRQRAa_DjA0cjhqyjuMYpKoAdYDJq3_i-rYAQ57XV1SoYE7uzAH6qvS153cGZPRVFYyD9834wWVAmGb97JQsuAoq6HTo2J1ja7yL8E6L92v0NPY32mFach8d4_FOQp_OtDgOwIL9RuBFeEnsu5gbviTHgt7sNvfc05a6MiSWJ .
   Google Scholar
• The State Council of the People’s Republic of China. COVID-19 vaccination free to Chinese residents: official. 2021 [accessed 2021 Mar 26]. http://english.www.gov.cn/statecouncil/ministries/202101/09/content_WS5ff94558c6d0f72576943854.html .
   Google Scholar
• Basta NE, Moodie EMM; on behalf of the McGill University COVID19 Vaccine Tracker Team. COVID-19 vaccine development and approvals tracker. [accessed 2021 Sep 22]. https://covid19.trackvaccines.org/country/china/ .
   Google Scholar
• National Health Commission of the People’s Republic of China. Over 1.49 bln doses of COVID-19 vaccines administered in China. 2021 [accessed 2021 Jul 24]. https://en.nhc.gov.cn/2021-07/15/c_84159.htm .
   Google Scholar
• Chinese Center for Disease Control and Prevention. Interpretation of adverse effect monitoring information for national COVID-19 vaccination. 2021 [accessed 2021 Jun 3]. http://www.chinacdc.cn/jkzt/ymyjz/ymyjjz_6758/202105/t20210528_230908.html .
   Google Scholar
• Frederiksen LSF, Zhang Y, Foged C, Thakur A. The long road toward COVID-19 herd immunity: vaccine platform technologies and mass immunization strategies. Front Immunol. 2020;11:1817. doi:10.3389/fimmu.2020.01817.
   PubMed Web of Science ®Google Scholar
• MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–64. doi:10.1016/j.vaccine.2015.04.036.
   PubMed Web of Science ®Google Scholar
• Craxì L, Casuccio A, Amodio E, Restivo V. Who should get COVID-19 vaccine first? A survey to evaluate hospital workers’ opinion. Vaccines (Basel). 2021;9(3):189. doi:10.3390/vaccines9030189.
   PubMed Web of Science ®Google Scholar
• Obregon R, Mosquera M, Tomsa S, Chitnis K. Vaccine hesitancy and demand for immunization in Eastern Europe and Central Asia: implications for the region and beyond. J Health Commun. 2020;25(10):808–15. doi:10.1080/10810730.2021.1879366.
   PubMed Web of Science ®Google Scholar
• Iyengar KP, Vaishya R, Jain VK, Ish P. BAME community hesitancy in the UK for COVID-19 vaccine: suggested solutions. Postgrad Med J. 2021 [accessed 2021 Mar 29]: postgradmedj-2021-139957. doi:10.1136/postgradmedj-2021-139957.
   Web of Science ®Google Scholar
• Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines (Basel). 2021;9(2):160. doi:10.3390/vaccines9020160.
   PubMed Web of Science ®Google Scholar
• Wang W, Wu Q, Yang J, Dong K, Chen X, Bai X, Chen X, Chen Z, Viboud C, Ajelli M, et al. Global, regional, and national estimates of target population sizes for covid-19 vaccination: descriptive study. BMJ. 2020;371:m4704. doi:10.1136/bmj.m4704.
   PubMed Web of Science ®Google Scholar
• Chen M, Li Y, Chen J, Wen Z, Feng F, Zou H, Fu C, Chen L, Shu Y, Sun C, et al. An online survey of the attitude and willingness of Chinese adults to receive COVID-19 vaccination. Hum Vaccines Immunother. 2021;17(7):2279–88. doi:10.1080/21645515.2020.1853449.
   PubMed Web of Science ®Google Scholar
• Su Z, Wen J, Abbas J, McDonnell D, Cheshmehzangi A, Li X, Ahmad J, Šegalo S, Maestro D, Cai Y, et al. A race for a better understanding of COVID-19 vaccine non-adopters. Brain Behav Immun Health. 2020;9:100159. doi:10.1016/j.bbih.2020.100159.
   PubMedGoogle Scholar
• Finney Rutten LJ, Zhu X, Leppin AL, Ridgeway JL, Swift MD, Griffin JM, St Sauver JL, Virk A, Jacobson RM. Evidence-based strategies for clinical organizations to address COVID-19 vaccine hesitancy. Mayo Clin Proc. 2021;96(3):699–707. doi:10.1016/j.mayocp.2020.12.024.
   PubMed Web of Science ®Google Scholar
• Laine C, Cotton D, Moyer DV. COVID-19 vaccine: promoting vaccine acceptance. Ann Intern Med. 2021;174(2):252–53. doi:10.7326/m20-8008.
   PubMed Web of Science ®Google Scholar
• World Health Organization. COVID-19: vulnerable and high risk groups. 2021 [accessed 2021 Mar 26]. https://www.who.int/westernpacific/emergencies/covid-19/information/high-risk-groups .
   Google Scholar
• Ssentongo P, Heilbrunn ES, Ssentongo AE, Advani S, Chinchilli VM, Nunez JJ, Du P. Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis. Sci Rep. 2021;11(1):6283. doi:10.1038/s41598-021-85359-3.
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO warns that HIV infection increases risk of severe and critical COVID-19. [accessed 2021 Sep 23]. https://www.who.int/news/item/15-07-2021-who-warns-that-hiv-infection-increases-risk-of-severe-and-critical-covid-19 .
   Google Scholar
• Bhaskaran K, Rentsch CT, MacKenna B, Schultze A, Mehrkar A, Bates CJ, Eggo RM, Morton CE, Bacon SCJ, Inglesby P. HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. Lancet HIV. 2021;8(1):e24–e32. doi:10.1016/s2352-3018(20)30305-2.
   PubMed Web of Science ®Google Scholar
• Jassat W, Cohen C, Tempia S, Masha M, Goldstein S, Kufa T, Murangandi P, Savulescu D, Walaza S, Bam JL, et al. Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study. Lancet HIV. 2021;8(9):e554–e567. doi:10.1016/s2352-3018(21)00151-x.
   PubMed Web of Science ®Google Scholar
• Deeks SG, Overbaugh J, Phillips A, Buchbinder S. HIV infection. Nat Rev Dis Primers. 2015;1:15035. doi:10.1038/nrdp.2015.35.
   PubMed Web of Science ®Google Scholar
• Sanchez TH, Zlotorzynska M, Rai M, Baral SD. Characterizing the impact of COVID-19 on men who have sex with men across the United States in April, 2020. AIDS Behav. 2020;24(7):2024–32. doi:10.1007/s10461-020-02894-2.
   PubMed Web of Science ®Google Scholar
• Kanwugu ON, Adadi P. HIV/SARS-CoV-2 coinfection: a global perspective. J Med Virol. 2021;93(2):726–32. doi:10.1002/jmv.26321.
   PubMed Web of Science ®Google Scholar
• Chou WS, Budenz A. Considering emotion in COVID-19 vaccine communication: addressing vaccine hesitancy and fostering vaccine confidence. Health Commun. 2020;35(14):1718–22. doi:10.1080/10410236.2020.1838096.
   PubMed Web of Science ®Google Scholar
• Barello S, Palamenghi L, Graffigna G. Looking inside the “black box” of vaccine hesitancy: unlocking the effect of psychological attitudes and beliefs on COVID-19 vaccine acceptance and implications for public health communication. Psychol Med. 2021 [accessed 2021 Mar 8]:1–5. doi:10.1017/s003329172100101x.
   PubMed Web of Science ®Google Scholar
• Trogen B, Oshinsky D, Caplan A. Adverse consequences of rushing a SARS-CoV-2 vaccine: implications for public trust. JAMA. 2020;323(24):2460–61. doi:10.1001/jama.2020.8917.
   PubMed Web of Science ®Google Scholar
• Harrison N, Poeppl W, Herkner H, Tillhof KD, Grabmeier-Pfistershammer K, Rieger A, Forstner C, Burgmann H, Lagler H. Predictors for and coverage of influenza vaccination among HIV-positive patients: a cross-sectional survey. HIV Med. 2017;18(7):500–06. doi:10.1111/hiv.12483.
   PubMed Web of Science ®Google Scholar
• Mohseni-Zadeh M, Rey D, Batard ML, Beck Wirth G, Partisani M-L, Lang J-M, Hansmann Y, Christmann D, Martinot M. Inadequate vaccination coverage in a French cohort of HIV positive patients. Med Mal Infect. 2010;40(12):683–90. doi:10.1016/j.medmal.2010.06.005.
   PubMed Web of Science ®Google Scholar
• Ambrosioni J, Blanco JL, Reyes-Urueña JM, Davies M-A, Sued O, Marcos MA, Martínez E, Bertagnolio S, Alcamí J, Miro JM. Overview of SARS-CoV-2 infection in adults living with HIV. Lancet HIV. 2021;8(5):e294–e305. doi:10.1016/s2352-3018(21)00070-9 .
   PubMed Web of Science ®Google Scholar
• ChinaDaily. Govt spells out groups not eligible for vaccination. 2021 [accessed 2021 Apr 15]. https://www.chinadaily.com.cn/a/202101/04/WS5ff26f41a31024ad0baa0342.html .
   Google Scholar
• Phoenix New Media. Exclusive|Zhong Nanshan calls for vaccination: don’t wait until foreign countries are immunized, China is dangerous. [accessed 2021 Apr 25]. https://v.ifeng.com/c/852HTO12J6W .
   Google Scholar
• National Health Commission of the People’s Republic of China. Health awareness among Chinese people rises in 2020. 2021 [accessed 2021 Apr 5]. http://en.nhc.gov.cn/2021-04/02/c_83377.htm .
   Google Scholar
• Benis A, Khodos A, Ran S, Levner E, Ashkenazi S. Social media engagement and influenza vaccination: a survey during the COVID-19 pandemic. J Med Internet Res. 2021;23(3):e25977. doi:10.2196/25977.
   PubMed Web of Science ®Google Scholar
• Zeballos Rivas DR, Lopez Jaldin ML, Nina Canaviri B, Portugal Escalante LF, Alanes Fernández AMC, Aguilar Ticona JP. Social media exposure, risk perception, preventive behaviors and attitudes during the COVID-19 epidemic in La Paz, Bolivia: a cross sectional study. PLoS One. 2021;16(1):e0245859. doi:10.1371/journal.pone.0245859.
   PubMed Web of Science ®Google Scholar
• National Health Commission of the People’s Republic of China. Technical guideline for the inoculation of COVID-19 vaccines. 2021 [accessed 2021 Apr 5]. http://en.nhc.gov.cn/2021-04/01/c_83365.htm .
   Google Scholar
• AIDS and Hepatitis C Professional Group, Chinese Society of Infectious Diseases. Expert recommendation for novel severe acute respiratory syndrome coronavirus 2 (SARS_CoV_2) vaccination in patients with HIV infection. Chin J Intern Med. 2021. doi:10.3760/cma.j.cn112138.20210403-00259.
   Google Scholar
• World Health Organization. WHO’s science in 5 on COVID-19: HIV & COVID-19. [accessed 2021 Sep 22]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/media-resources/science-in-5/episode-48—hiv-covid-19?gclid=Cj0KCQjwqKuKBhCxARIsACf4XuEmSRVHWk7zUgp-fibKSZp2PF5_XP8gHQT5z13ceWJESnUENtCzq8IaAnduEALw_wcB .
   Google Scholar
• HIV.gov. Interim guidance for COVID-19 and persons with HIV. [accessed 2021 Sep 22]. https://clinicalinfo.hiv.gov/en/guidelines/covid-19-and-persons-hiv-interim-guidance/interim-guidance-covid-19-and-persons-hiv?view=full .
   Google Scholar
• Press conference of the Joint Prevention and Control Mechanism of the State Council. Introduction of the situation regarding further prevention and control of the COVID-19 and vaccination on September 7, 2021. [accessed 2021 Sep 22]. http://www.nhc.gov.cn/xwzb/webcontroller.do?titleSeq=11400&gecstype=1 .
   Google Scholar
• Trovato M, Sartorius R, D’Apice L, Manco R, De Berardinis P. Viral emerging diseases: challenges in developing vaccination strategies. Front Immunol. 2020;11:2130. doi:10.3389/fimmu.2020.02130.
   PubMed Web of Science ®Google Scholar
• Xinhuanet. The number of people covered by COVID-19 vaccination have reached 1.1 billion in China, over 1 billion people complete the entire vaccination process. [accessed 2021 Sep 22]. http://m.news.cn/2021-09/19/c_1127881191.htm .
   Google Scholar
• Gómez CE, Perdiguero B, Esteban M. SARS emerging -CoV-2 variants and impact in global vaccination programs against SARS-CoV-2/COVID-19. Vaccines (Basel). 2021;9(3):243. doi:10.3390/vaccines9030243.
   PubMed Web of Science ®Google Scholar
• Shimizu K, Wharton G, Sakamoto H, Mossialos E. Resurgence of covid-19 in Japan. BMJ. 2020;370:m3221. doi:10.1136/bmj.m3221.
   PubMed Web of Science ®Google Scholar
• Agut H. COVID-19, September 2020: fall storm warning. Virologie (Montrouge). 2020;24(6):361–67. doi:10.1684/vir.2020.0865.
   PubMedGoogle Scholar
• Devi S. COVID-19 resurgence in Iran. Lancet. 2020;395(10241):1896. doi:10.1016/s0140-6736(20)31407-0.
   PubMed Web of Science ®Google Scholar
• Zhang K, Vilches TN, Tariq M, Galvani AP, Moghadas SM. The impact of mask-wearing and shelter-in-place on COVID-19 outbreaks in the United States. Int J Infect Dis. 2020;101:334–41. doi:10.1016/j.ijid.2020.10.002.
   PubMed Web of Science ®Google Scholar